Global Retirement Partners
ACTU icon

Global Retirement Partners’s Actuate Therapeutics ACTU Stock Holding History

Global Retirement Partners’s Portfolio ACTU Stock Details ACTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.6K Buy
+6,250
New +$14.5K ﹤0.01% 3419
2025
Q4 		$38.2K Hold
6,250
– – ﹤0.01% 2512
2025
Q3 		$41.8K Hold
6,250
– – ﹤0.01% 1998
2025
Q2 		$38.2K Buy
+6,250
New +$54.6K ﹤0.01% 1925

Other funds holding ACTU

BIOS Capital Management
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
Voss Capital
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Texas Capital Bank Wealth Management Services
Texas Capital Bank Wealth Management Services Dallas, Texas $1.87B AUM 24.49% 1-Year Est. Return
Palogic Value Management
Palogic Value Management Dallas, Texas $306M AUM 15.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ABS Direct Equity Fund
ABS Direct Equity Fund Stamford, Connecticut $159M AUM 34.17% 1-Year Est. Return

Global Retirement Partners's ACTU Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Actuate Therapeutics (ACTU) in Q2 2026: 6,250 shares worth $9.6K. The stake represents ﹤0.01% of the portfolio and ranks #3419 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in ACTU as recently as Q4 2025.

Global Retirement Partners first reported a position in ACTU in Q2 2025 and has held it in 4 quarters since. The position peaked at $41.8K in Q3 2025. 63 funds tracked by Wall St. Rank hold ACTU as of Q2 2026.

  • Global Retirement Partners held 6,250 shares of Actuate Therapeutics worth $9.6K as of Q2 2026.
  • Actuate Therapeutics was a new Global Retirement Partners position in Q2 2026.
  • Actuate Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #3419 holding.
  • Global Retirement Partners first reported a position in Actuate Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • Global Retirement Partners's Actuate Therapeutics position peaked at $41.8K in Q3 2025.
  • 63 funds tracked by Wall St. Rank held Actuate Therapeutics as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.